Several commenters indicated how complete, accurate, and timely price transparency can be a powerful tool allowing employers, innovators, researchers, policy makers, and public and private payers to have a truer picture of where cost pressures may lie and how they may be mitigated
The decarbonization planning process is underway, with a first campus-specific study finalized in May 2025
Further research is needed to fully elucidate the effects of IFP on breast cancer metastasis as well as the mechanisms governing pressure-induced responses
Currently, several obesity companies, such as YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSirt Biopharma, Novartis,, and others, across the globe are developing obesity therapies